Fujimori Kogyo Co AI Stock Analysis
Want to see JP:7917 full AI Analyst Report?
Fujimori Kogyo Co (7917) AI Stock Analysis
Fujimori Kogyo Co
(TSE/TYO:7917)
Fujimori Kogyo's strong balance sheet and steady revenue growth provide a solid foundation, though recent cash flow is negative due to investments. Technicals show short-term weakness but oversold conditions, while valuation remains reasonable. The overall score of 70 reflects a moderately attractive investment with some near-term caution.
Fujimori Kogyo Co (7917) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 102.64B
- Dividend Yield
- 2.82%
- Average Volume (3M)
- 153.73K
- Price to Earnings (P/E)
- 11.5
- Beta (1Y)
- 0.86
- Revenue Growth
- 7.89%
- EPS Growth
- 26.59%
- Country
- Japan
- Employees
- 2,747
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Packaging & Containers
Fujimori Kogyo Co Business Overview & Revenue Model
Company Description
Fujimori Kogyo Co., Ltd., founded in Tokyo, Japan, in 1914, is a global provider of diverse packaging materials, specialized medical and pharmaceutical packaging solutions, and advanced functional components. The company operates through its Life Sci...
How the Company Makes Money
null
Fujimori Kogyo Co Financial Statement Overview
Summary
Fujimori Kogyo shows steady revenue growth and a strong balance sheet with low debt (D/E 0.13), but cash flow has been negative due to high capex. Income statement score 75, balance sheet 85, cash flow 60, averaging to a solid financial performance.
Income Statement
75PositiveBalance Sheet
85Very PositiveCash Flow
60Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 165.74B | 158.53B | 150.74B | 136.16B | 129.36B | 127.82B |
| Gross Profit | 38.56B | 36.81B | 34.74B | 29.75B | 25.71B | 28.68B |
| EBITDA | 20.19B | 18.71B | 15.81B | 13.23B | 13.00B | 16.56B |
| Net Income | 8.39B | 7.71B | 6.53B | 4.53B | 4.85B | 7.69B |
Balance Sheet | ||||||
| Total Assets | 162.30B | 156.79B | 153.93B | 141.68B | 128.44B | 127.37B |
| Cash, Cash Equivalents and Short-Term Investments | 16.47B | 14.84B | 22.48B | 32.11B | 30.62B | 28.15B |
| Total Debt | 9.89B | 12.33B | 6.25B | 3.13B | 3.12B | 2.53B |
| Total Liabilities | 53.95B | 52.45B | 53.23B | 48.04B | 39.16B | 42.15B |
| Stockholders Equity | 98.83B | 95.20B | 92.00B | 85.96B | 82.45B | 79.34B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -9.56B | -11.14B | 3.15B | 3.23B | 6.10B |
| Operating Cash Flow | 0 | 11.78B | 6.59B | 10.08B | 8.37B | 11.40B |
| Investing Cash Flow | 0 | -20.41B | -17.46B | -6.10B | -3.97B | -5.18B |
| Financing Cash Flow | 0 | 527.00M | 269.00M | -3.51B | -2.44B | -2.77B |
Fujimori Kogyo Co Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7917, the sentiment is Positive. The current price of 1346.00 is above the 20-day moving average (MA) of 1250.60, above the 50-day MA of 1236.86, and above the 200-day MA of 1287.99, indicating a bullish trend. The MACD of 18.62 indicates Negative momentum. The RSI at 70.37 is Negative, neither overbought nor oversold. The STOCH value of 96.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7917.
Fujimori Kogyo Co Peers Comparison
Overall Rating
JP:395083.1Outperform
JP:794278Outperform
JP:786477Outperform
JP:395476Outperform
JP:791770Outperform
JP:395169Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | JPY 89.07B | 14.91 | ― | 2.60% | 5.15% | 5.91% | |
| 78Outperform | JPY 76.39B | 8.08 | ― | 3.41% | 14.19% | 90.30% | |
| 77Outperform | JPY 188.07B | 8.80 | 13.51% | 2.54% | 7.02% | 32.46% | |
| 76Outperform | JPY 13.39B | 7.90 | ― | 1.81% | 5.61% | 41.64% | |
| 70Outperform | JPY 102.64B | 11.51 | 8.74% | 2.82% | 7.89% | 26.59% | |
| 69Neutral | JPY 19.26B | 10.87 | ― | 4.17% | 2.37% | 42.02% | |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7917 | Fujimori Kogyo Co | 1346.00 | 290.10 | 27.47% | |
| JP:7864 | Fuji Seal International | 3510.00 | 650.66 | 22.76% | |
| JP:3950 | Pack Corporation | 1502.00 | 279.27 | 22.84% | |
| JP:3951 | Asahi Printing Co., Ltd. | 911.00 | 72.69 | 8.67% | |
| JP:3954 | SHOWA PAXXS CORP. | 3040.00 | 221.96 | 7.88% | |
| JP:7942 | JSP Corporation | 3140.00 | 1085.87 | 52.86% |
Fujimori Kogyo Co Corporate Events
ZACROS Highlights Diversified Segment Strategy in Q1 FY2026 Materials
ZACROS Corporation outlined its diversified business structure in its first-quarter materials for fiscal 2026, emphasizing a strategic focus on wellness, environmental solutions, electronic materials, and industrial infrastructure. By highlighting ke...
ZACROS lifts sales and profit as it expands footprint, keeps full-year forecast intact
ZACROS Corporation reported consolidated net sales of ¥41.4 billion for the quarter ended June 30, 2026, up 5.4% year on year, while operating income slipped 2.9% to ¥3.36 billion and ordinary income fell 4.6%. Net income attributable to owners of th...
ZACROS to Grant Restricted Treasury Stock to Directors and Executives
ZACROS Corporation has approved the disposal of 38,900 treasury shares as restricted stock to three directors and four executive officers as part of its equity-based compensation program. The shares for directors will be granted as non-cash compensat...
ZACROS Ends Share Buyback After Repurchasing 1.1 Million Shares
ZACROS Corporation has completed a share repurchase program conducted under a Board-approved resolution aimed at maintaining a flexible capital policy in response to changes in its business environment. The company acquired 163,400 shares for ¥201,93...
ZACROS Reshapes Board and Audit Structure at 96th Shareholders’ Meeting
ZACROS Corporation has confirmed the reelection of key board members, including Chairman Akihiko Fujimori and President Taku Shimoda, at its 96th Annual General Meeting of Shareholders in Tokyo. Senior Vice President Michihiko Sato and Norihiro Kusak...
ZACROS Corrects Segment Impairment Loss Figures in FY2026 Results
ZACROS CORPORATION has issued a correction to its previously disclosed consolidated financial results for the fiscal year ended March 31, 2026, under Japanese GAAP, after identifying an error in the impairment loss figures within its segment informat...
ZACROS Details Progress on Ongoing Share Buyback Program
ZACROS Corporation reported progress on its ongoing share buyback program authorized by its board in November 2025, conducted under the Companies Act of Japan and the firm’s Articles of Incorporation. Between May 1 and May 31, 2026, the company repur...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
